Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
Clinical trial NCT01421173 · COMPLETED
Trial details
- NCT number
- NCT01421173
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2015-09-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.